Impacts of intensive insulin therapy in patients undergoing heart valve replacement

Heart Surgery Forum

Volumn 13, Issue 5, 2010, Pages

  Zheng, Rehong ^a   Gu, Chunhu ^a   Wang, Yunya ^a   Yang, Zengyue ^b   Dou, Kefeng ^a   Wang, Jing ^a   Yu, Siqiang ^a   Wang, Hongbing ^a   Xie, Jiaqi ^a   Wang, Yuemin ^a   Yi, Dinghua ^a   Pei, Jianming ^a,b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLUCOSE; INOTROPIC AGENT; INSULIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AORTA VALVE REPLACEMENT; ARTICLE; ARTIFICIAL VENTILATION; BLOOD GLUCOSE MONITORING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INSULIN TREATMENT; INTENSIVE CARE; MALE; MITRAL VALVE REPLACEMENT; MORTALITY; PATIENT MONITORING; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

ADULT; BLOOD GLUCOSE; BLOTTING, WESTERN; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; TREATMENT OUTCOME;

EID: 78049340705     PISSN: 10983511     EISSN: 15226662     Source Type: Journal    
DOI: 10.1532/HSF98.20101017     Document Type: Article

References (25)

1. Aebert H, Kirchner S, Keyser A, et al. 2000. Endothelial apoptosis is induced by serum of patients after cardiopulmonary bypass. Eur J Cardiothorac Surg 18:589-93.
2. Asahara T, Masuda H, Takahashi T, et al. 1999. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85:221-8.
3. Collard CD, Gelman S. 2001. Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology 94:1133-8. (Pubitemid 32506143)
4. Dandona P, Aljada A, Mohanty P. 2002. The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia 45:924-30.
5. Das UN. 2006. Pyruvate is an endogenous anti-inflammatory and antioxidant molecule. Med Sci Monit 12:RA79-84.
6. Das UN. 2006. Glucose, insulin, and acute myocardial infarction. Eur Heart J 27:2141-3.
7. Doenst T, Wijeysundera D, Karkouti K, et al. 2005. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 130:1144-51.
8. Furnary AP, Wu Y. 2006. Clinical effects of hyperglycemia in the cardiac surgery population: the Portland Diabetic Project. Endocr Pract 12:22-6.
9. Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. 1999. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care 22:1408-14.
10. Griesdale DE, de Souza RJ, van Dam RM, et al. 2009. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 180:821-7.
11. Gu CH, Cui Q, Wang YY, et al. 2008. Effects of insulin therapy on inflammatory mediators in infants undergoing cardiac surgery with cardiopulmonary bypass. Cytokine 44:96-100.
12. Gu CH, Wei XF, Wang YY, et al. 2008. No infection with porcine endogenous retrovirus in recipients of acellular porcine aortic valves: a two-year study. Xenotransplantation 15:121-8.
13. Ha H, Yu MR, Choi YJ, Kitamura M, Lee HB. 2002. Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells. J Am Soc Nephrol 13:894-902. (Pubitemid 34274085)
14. Jeschke MG, Klein D, Bolder U, Einspanier R. 2004. Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology 145:4084-93. (Pubitemid 39120556)
15. Koh TW, Hooper J, Kemp M, Ferdinand FD, Gibson DG, Pepper JR. 1998. Intraoperative release of troponin T in coronary venous and arterial blood and its relation to recovery of left ventricular function and oxidative metabolism following coronary artery surgery. Heart 80:341-8.
16. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. 2004. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 109:1497-502. (Pubitemid 38420177)
17. Rassias AJ. 2006. Intraoperative management of hyperglycemia in the cardiac surgical patient. Semin Thorac Cardiovasc Surg 18:330-8.
18. Shilling AM, Raphael J. 2008. Diabetes, hyperglycemia, and infections. Best Pract Res Clin Anaesthesiol 22:519-35.
19. Shore S, Nelson DP, Pearl JM, et al. 2001. Usefulness of corticosteroid therapy in decreasing epinephrine requirements in critically ill infants with congenital heart disease. Am J Cardiol 88:591-4. (Pubitemid 32778518)
20. Taylor JH, Beilman GJ. 2005. Hyperglycemia in the intensive care unit: no longer just a marker of illness severity. Surg Infect (Larchmt) 6:233-45.
21. Tracey KJ, Fong Y, Hesse DG, et al. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662-4. (Pubitemid 18005583)
22. Tripathy D, Mohanty P, Dhindsa S, et al. 2003. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes 52:2882-7.
23. van den Berghe G, Wilmer A, Hermans G, et al. 2006. Intensive insulin therapy in the medical ICU. N Engl J Med 354:449-61. (Pubitemid 43200296)
24. van den Berghe G, Wouters P, Weekers F, et al. 2001. Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359-67.
25. Wang H, Bloom O, Zhna M, et al. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248-51.